RDWhat are Biomarkers and How Might They Influence the Future of Cancer Care?From Patient Outcomes to Drug Development, biomarkers hold a promise for improved care. But are there any caveats?Dec 3, 2019Dec 3, 2019
RDGenetic Data, Privacy, and PerilA call for greater protections amongst the US’s fractured legal landscapeSep 19, 2019Sep 19, 2019
RDFinancial Toxicity and Cancer Care in the United States“How the staggering financial burden placed on cancer patients by the US healthcare system results in catastrophic effects for health…Sep 5, 2019Sep 5, 2019
RDAI Accountability and Healthcare InequityA deeper look into healthcare disparities in the U.S. and what experts say we must do to ensure healthcare tech enables more equitable…Jul 23, 2019Jul 23, 2019
RDCancer Culture: A Captive FearHow fear shapes the experience of cancer and how its unpacking can lead us to a politics of collective actionJun 28, 2019Jun 28, 2019
RDPatient Perceptions Of AI-Driven SystemsWith the introduction of computer-assisted clinical decision support tools in the nineteen-seventies, the development of A.I. systems for…Jun 11, 2019Jun 11, 2019
RDNotes On ‘Ethics, Justice And Knowledge After The Genome’Lessons from Professor J. Reardon’s The Postgenomic Condition (2017, University of Chicago Press)May 9, 2019May 9, 2019
RDOur Bodies, Our Data?Who owns your personal medical data? Who can share your medical data? What are the laws surrounding health data? Is ‘anonymized’ personal…Mar 1, 2019Mar 1, 2019
RDOn Health Equity And AIDriving questions for the development of AI-driven systems for healthcareFeb 20, 2019Feb 20, 2019